The document outlines Quezon City's disease surveillance and contact tracing system for COVID-19. It describes data sources, the data management process, contact tracing conducted by health centers, and workplace surveillance. Key aspects of the system include identifying suspected, probable and confirmed COVID-19 cases; classifying case severity; performing initial contact tracing in schools; and notifying the Epidemiology and Surveillance Unit to initiate full contact tracing and case management through local health centers. The goal is to allow early detection and control of COVID-19 transmission through coordinated public health surveillance and response.
This document summarizes information from Dr. Tahseen J. Siddiqui on COVID-19. It discusses the three known coronaviruses that cause SARS, MERS, and COVID-19. It emphasizes that mitigation through strict social isolation is the best current strategy to slow transmission rates and prevent healthcare systems from being overwhelmed. The risks of personal infection are low but systemic risks are high if many require critical care simultaneously. Early action through testing, contact tracing, and quarantines have helped countries like Taiwan better control the spread.
The document provides information on SARS-CoV-2, the virus that causes COVID-19, including its origins and symptoms. It discusses NSW Health's response to an outbreak of the virus in Australia, including procedures for identifying and managing cases, infection control strategies, and guidance for healthcare workers. The document also contains technical details about the virus and disease.
This document discusses COVID-19, caused by SARS-CoV-2. It defines the virus and outlines its origin in Wuhan, China in December 2019. Clinical features include fever, cough and dyspnea. Diagnosis involves travel history screening and PCR testing of respiratory samples. Management involves supportive care, with oxygen and ventilation for severe cases. Specific antivirals like remdesivir are under investigation but no vaccine currently exists. Prognosis is best for non-critical cases without comorbidities, with a overall fatality rate of 2.3%.
This presentation provides an overview of COVID-19 and was given by Team-D from the Department of Family Medicine at University of Uyo Teaching Hospital. It discusses the history, epidemiology, pathophysiology, clinical features, treatment, prevention and the role of family physicians in addressing the COVID-19 pandemic. Key points include that COVID-19 is caused by the SARS-CoV-2 virus, over 404 million confirmed cases worldwide as of February 2022, and prevention strategies involve vaccination, personal protective measures, and infection control in healthcare settings. The family physician plays an important role in identifying and managing potential COVID-19 cases at the primary care level.
This document provides information about COVID-19 presented by Dr. Mahasin Shaddad, including: discussing the modes of transmission, incubation period, clinical presentation, case definitions, and specimen collection for diagnosis. It outlines that COVID-19 is caused by a novel coronavirus that was first detected in China and has now spread internationally. The main modes of transmission are through respiratory droplets from coughing or sneezing. The median incubation period is 5 days, with a maximum of 14 days. Risk factors for severe illness include older age and pre-existing medical conditions.
This revised guideline from the Government of India provides guidance on clinical management of COVID-19 patients. It outlines case definitions, clinical features, infection prevention and control measures, laboratory diagnosis, early supportive care including oxygen therapy and antimicrobials, and monitoring patients for deterioration. While corticosteroids are not routinely recommended, supportive care including conservative fluid resuscitation and timely management of sepsis or respiratory failure is emphasized.
This document provides information on COVID-19 including its structural characteristics, epidemiology, case definition, diagnosis, and care of healthcare workers. It describes COVID-19 as a respiratory illness caused by a novel coronavirus (SARS-CoV-2) that ranges from mild to severe symptoms. Key points include modes of transmission, risk factors like age and pre-existing conditions, stages of illness, global and local case statistics, and steps healthcare workers should take like using proper PPE, hand hygiene, and isolation protocols to care for patients and protect themselves.
This document summarizes information from Dr. Tahseen J. Siddiqui on COVID-19. It discusses the three known coronaviruses that cause SARS, MERS, and COVID-19. It emphasizes that mitigation through strict social isolation is the best current strategy to slow transmission rates and prevent healthcare systems from being overwhelmed. The risks of personal infection are low but systemic risks are high if many require critical care simultaneously. Early action through testing, contact tracing, and quarantines have helped countries like Taiwan better control the spread.
The document provides information on SARS-CoV-2, the virus that causes COVID-19, including its origins and symptoms. It discusses NSW Health's response to an outbreak of the virus in Australia, including procedures for identifying and managing cases, infection control strategies, and guidance for healthcare workers. The document also contains technical details about the virus and disease.
This document discusses COVID-19, caused by SARS-CoV-2. It defines the virus and outlines its origin in Wuhan, China in December 2019. Clinical features include fever, cough and dyspnea. Diagnosis involves travel history screening and PCR testing of respiratory samples. Management involves supportive care, with oxygen and ventilation for severe cases. Specific antivirals like remdesivir are under investigation but no vaccine currently exists. Prognosis is best for non-critical cases without comorbidities, with a overall fatality rate of 2.3%.
This presentation provides an overview of COVID-19 and was given by Team-D from the Department of Family Medicine at University of Uyo Teaching Hospital. It discusses the history, epidemiology, pathophysiology, clinical features, treatment, prevention and the role of family physicians in addressing the COVID-19 pandemic. Key points include that COVID-19 is caused by the SARS-CoV-2 virus, over 404 million confirmed cases worldwide as of February 2022, and prevention strategies involve vaccination, personal protective measures, and infection control in healthcare settings. The family physician plays an important role in identifying and managing potential COVID-19 cases at the primary care level.
This document provides information about COVID-19 presented by Dr. Mahasin Shaddad, including: discussing the modes of transmission, incubation period, clinical presentation, case definitions, and specimen collection for diagnosis. It outlines that COVID-19 is caused by a novel coronavirus that was first detected in China and has now spread internationally. The main modes of transmission are through respiratory droplets from coughing or sneezing. The median incubation period is 5 days, with a maximum of 14 days. Risk factors for severe illness include older age and pre-existing medical conditions.
This revised guideline from the Government of India provides guidance on clinical management of COVID-19 patients. It outlines case definitions, clinical features, infection prevention and control measures, laboratory diagnosis, early supportive care including oxygen therapy and antimicrobials, and monitoring patients for deterioration. While corticosteroids are not routinely recommended, supportive care including conservative fluid resuscitation and timely management of sepsis or respiratory failure is emphasized.
This document provides information on COVID-19 including its structural characteristics, epidemiology, case definition, diagnosis, and care of healthcare workers. It describes COVID-19 as a respiratory illness caused by a novel coronavirus (SARS-CoV-2) that ranges from mild to severe symptoms. Key points include modes of transmission, risk factors like age and pre-existing conditions, stages of illness, global and local case statistics, and steps healthcare workers should take like using proper PPE, hand hygiene, and isolation protocols to care for patients and protect themselves.
The document provides information about COVID-19 and the NSW Health response. It defines SARS-CoV-2, the virus that causes COVID-19, and details the timeline of the outbreak worldwide and in Australia. It describes NSW Health's response, which includes establishing clinical councils, providing advice to healthcare workers, developing diagnostic tests, managing cases through infection control and public health measures, and regular public updates. It provides guidance on case definitions, testing criteria, and infection prevention and control strategies to prevent transmission, including the use of personal protective equipment and isolation for suspected or confirmed cases.
Coronaviruses can cause respiratory illnesses in humans ranging from the common cold to more severe diseases like MERS and SARS. They are transmitted through airborne droplets and contaminated surfaces. While most coronavirus infections cause mild illness, MERS can lead to severe pneumonia and organ failure. At risk groups include the elderly, immunocompromised, and those with chronic conditions. Treatment focuses on supportive care, while prevention emphasizes hand hygiene, respiratory etiquette, and personal protective equipment for healthcare workers.
The document provides information on COVID-19 (coronavirus disease 2019), caused by the novel coronavirus SARS-CoV-2. It discusses the virus's origins, symptoms, transmission, incubation period, case definitions, screening and testing procedures, treatment and prevention recommendations including isolation, use of personal protective equipment, hand hygiene, and monitoring of healthcare workers.
This document provides information on COVID-19, including that it is caused by a coronavirus that commonly infects humans and animals. The virus spreads mainly through respiratory droplets from coughing or sneezing. Most cases are mild, but some develop severe pneumonia requiring hospitalization. Diagnosis is via PCR testing of respiratory samples. While there is no vaccine, potential treatments include chloroquine and supportive care. Public health measures aim to test, isolate cases and trace contacts to control spread.
This document provides guidance on the initial management and treatment of COVID-19. It discusses triaging patients with suspected COVID-19 and implementing appropriate infection prevention and control measures. It recommends hospitalizing high-risk patients or those with severe acute respiratory infection (SARI) complications. Treatment options discussed include oxygen therapy, antimicrobial therapy, and care of SARI patients in emergency and ICU settings. Specimen collection and safe patient transfer are also covered.
This document provides an overview of COVID-19 including its timeline, transmission, presentation, epidemiology, prevention, and containment plan. It discusses that COVID-19 is a respiratory infection caused by SARS-CoV-2. It outlines the timeline of the outbreak beginning in December 2019 in Wuhan, China. It also discusses transmission modes, signs and symptoms, disease progression, prevention strategies like isolation, quarantine, hand hygiene, and use of personal protective equipment.
The document discusses surveillance of COVID-19, including definitions, objectives, and types of surveillance. Surveillance is defined as the ongoing collection and analysis of health-related data to improve public health. The objectives of COVID-19 surveillance are to rapidly detect cases and contain outbreaks. Types of surveillance discussed are active surveillance through house-to-house searches, passive surveillance through health facilities, and sentinel surveillance through targeted testing. Limitations include underdetection of mild and asymptomatic cases.
- The document discusses COVID-19, providing details on its origins in Wuhan, China in December 2019, symptoms, transmission, screening procedures, and prevention methods. It outlines that COVID-19 is a novel coronavirus that causes respiratory illness, with symptoms ranging from mild to severe. Prevention focuses on hand washing, social distancing, and isolation of suspected cases.
The document provides guidelines for dealing with cases of Middle East respiratory syndrome coronavirus (MERS-CoV). It discusses what MERS-CoV infections may look like clinically, including symptoms like fever, cough and shortness of breath. It provides criteria for who should be tested for MERS-CoV, such as those with severe acute respiratory illness who have traveled to the Middle East. It also outlines appropriate infection control measures, like droplet and contact precautions, to prevent transmission in healthcare settings. Currently there is no antiviral treatment available for MERS-CoV.
This document outlines the role of health departments in responding to COVID-19. It discusses the strategic approach to different outbreak scenarios and key interventions like surveillance, contact tracing, and clinical case management. It provides definitions for suspected and confirmed COVID-19 cases and describes containment strategies for different outbreak levels. The strategies include surveillance and restrictions in containment and buffer zones. It also discusses border measures, risk communication, and surge capacity planning.
This document provides guidance on the care of patients with COVID-19. It defines COVID-19 and outlines the objectives of reviewing its history, case definition, clinical manifestations, diagnostic testing, medical management, prevention, and nursing care. It describes the virus's structure and history. Key points include its identification in China in late 2019, its declaration as a global pandemic by WHO in March 2020, and its spread to over 160 countries. Clinical features range from mild illness to pneumonia, ARDS, and septic shock. Diagnostic testing includes PCR from respiratory samples and serology. Management involves symptomatic care, oxygen therapy, treatment of coinfections, ventilation for respiratory failure, and treating septic shock.
This document provides a presentation on COVID-19 given by Dr. Shiva Kandel. It includes epidemiological data on COVID-19 cases and deaths in Nepal as of June 9, 2021. It also covers the virology, variants, transmission, prevention, classification, symptoms, investigations, treatment guidelines, complications and long-term effects of COVID-19. Myth busters and guidelines from WHO, IDSA and TUTH on testing, management and thromboprophylaxis are discussed.
1. The document discusses the etiological characteristics, clinical manifestations, and management of the novel coronavirus (COVID-19). It describes how the virus spreads through respiratory droplets and contact, and its symptoms which range from asymptomatic to severe.
2. Diagnosis involves PCR testing of respiratory samples, chest imaging showing pneumonia, and elevated inflammatory markers in severe cases. Treatment involves isolation, supportive care, and management of complications.
3. Prevention strategies include hand washing, physical distancing, and disinfecting surfaces. The document also proposes some Unani formulations that may provide adjuvant therapy for COVID-19.
This document provides information for nursing professionals on COVID-19 in post-acute care facilities. It discusses the origin and spread of the virus, symptoms, diagnosis and treatment. It emphasizes the importance of infection control through proper hand hygiene, use of personal protective equipment, monitoring residents, adjusting visitor policies, and encouraging employee responsibility. Key recommendations include limiting how many germs enter the facility, isolating symptomatic residents, and protecting healthcare workers through appropriate use of PPE.
This document summarizes information about COVID-19 for nursing professionals working in post-acute care facilities. It discusses the origin and spread of the virus, symptoms, diagnosis and treatment. It emphasizes the importance of strict infection control practices, including excellent hand hygiene, monitoring residents for symptoms, and providing appropriate personal protective equipment for healthcare workers. Healthcare workers are urged to take action to reduce transmission rates and prevent overwhelming local healthcare systems.
This document provides information for nursing professionals on COVID-19 in post-acute care facilities. It discusses the origin and spread of the virus, symptoms, diagnosis and treatment. It emphasizes the importance of infection control through hygiene, monitoring residents, appropriate use of PPE, encouraging employee responsibility and adjusting visitor policies. Key recommendations include limiting how germs enter the facility, isolating symptomatic residents, and protecting staff through proper PPE use.
The document discusses laboratory diagnostics for COVID-19. It describes how reverse transcriptase polymerase chain reaction (RT-PCR) tests performed on respiratory specimens like nasal or throat swabs are the current reference standard for diagnosis. Point-of-care tests and serological immunoassays that detect antibodies are also emerging. The document outlines considerations for different types of tests and discusses interpreting results, safety handling of specimens, and highlights the importance of diagnostic testing in controlling the pandemic.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
The document provides information about COVID-19 and the NSW Health response. It defines SARS-CoV-2, the virus that causes COVID-19, and details the timeline of the outbreak worldwide and in Australia. It describes NSW Health's response, which includes establishing clinical councils, providing advice to healthcare workers, developing diagnostic tests, managing cases through infection control and public health measures, and regular public updates. It provides guidance on case definitions, testing criteria, and infection prevention and control strategies to prevent transmission, including the use of personal protective equipment and isolation for suspected or confirmed cases.
Coronaviruses can cause respiratory illnesses in humans ranging from the common cold to more severe diseases like MERS and SARS. They are transmitted through airborne droplets and contaminated surfaces. While most coronavirus infections cause mild illness, MERS can lead to severe pneumonia and organ failure. At risk groups include the elderly, immunocompromised, and those with chronic conditions. Treatment focuses on supportive care, while prevention emphasizes hand hygiene, respiratory etiquette, and personal protective equipment for healthcare workers.
The document provides information on COVID-19 (coronavirus disease 2019), caused by the novel coronavirus SARS-CoV-2. It discusses the virus's origins, symptoms, transmission, incubation period, case definitions, screening and testing procedures, treatment and prevention recommendations including isolation, use of personal protective equipment, hand hygiene, and monitoring of healthcare workers.
This document provides information on COVID-19, including that it is caused by a coronavirus that commonly infects humans and animals. The virus spreads mainly through respiratory droplets from coughing or sneezing. Most cases are mild, but some develop severe pneumonia requiring hospitalization. Diagnosis is via PCR testing of respiratory samples. While there is no vaccine, potential treatments include chloroquine and supportive care. Public health measures aim to test, isolate cases and trace contacts to control spread.
This document provides guidance on the initial management and treatment of COVID-19. It discusses triaging patients with suspected COVID-19 and implementing appropriate infection prevention and control measures. It recommends hospitalizing high-risk patients or those with severe acute respiratory infection (SARI) complications. Treatment options discussed include oxygen therapy, antimicrobial therapy, and care of SARI patients in emergency and ICU settings. Specimen collection and safe patient transfer are also covered.
This document provides an overview of COVID-19 including its timeline, transmission, presentation, epidemiology, prevention, and containment plan. It discusses that COVID-19 is a respiratory infection caused by SARS-CoV-2. It outlines the timeline of the outbreak beginning in December 2019 in Wuhan, China. It also discusses transmission modes, signs and symptoms, disease progression, prevention strategies like isolation, quarantine, hand hygiene, and use of personal protective equipment.
The document discusses surveillance of COVID-19, including definitions, objectives, and types of surveillance. Surveillance is defined as the ongoing collection and analysis of health-related data to improve public health. The objectives of COVID-19 surveillance are to rapidly detect cases and contain outbreaks. Types of surveillance discussed are active surveillance through house-to-house searches, passive surveillance through health facilities, and sentinel surveillance through targeted testing. Limitations include underdetection of mild and asymptomatic cases.
- The document discusses COVID-19, providing details on its origins in Wuhan, China in December 2019, symptoms, transmission, screening procedures, and prevention methods. It outlines that COVID-19 is a novel coronavirus that causes respiratory illness, with symptoms ranging from mild to severe. Prevention focuses on hand washing, social distancing, and isolation of suspected cases.
The document provides guidelines for dealing with cases of Middle East respiratory syndrome coronavirus (MERS-CoV). It discusses what MERS-CoV infections may look like clinically, including symptoms like fever, cough and shortness of breath. It provides criteria for who should be tested for MERS-CoV, such as those with severe acute respiratory illness who have traveled to the Middle East. It also outlines appropriate infection control measures, like droplet and contact precautions, to prevent transmission in healthcare settings. Currently there is no antiviral treatment available for MERS-CoV.
This document outlines the role of health departments in responding to COVID-19. It discusses the strategic approach to different outbreak scenarios and key interventions like surveillance, contact tracing, and clinical case management. It provides definitions for suspected and confirmed COVID-19 cases and describes containment strategies for different outbreak levels. The strategies include surveillance and restrictions in containment and buffer zones. It also discusses border measures, risk communication, and surge capacity planning.
This document provides guidance on the care of patients with COVID-19. It defines COVID-19 and outlines the objectives of reviewing its history, case definition, clinical manifestations, diagnostic testing, medical management, prevention, and nursing care. It describes the virus's structure and history. Key points include its identification in China in late 2019, its declaration as a global pandemic by WHO in March 2020, and its spread to over 160 countries. Clinical features range from mild illness to pneumonia, ARDS, and septic shock. Diagnostic testing includes PCR from respiratory samples and serology. Management involves symptomatic care, oxygen therapy, treatment of coinfections, ventilation for respiratory failure, and treating septic shock.
This document provides a presentation on COVID-19 given by Dr. Shiva Kandel. It includes epidemiological data on COVID-19 cases and deaths in Nepal as of June 9, 2021. It also covers the virology, variants, transmission, prevention, classification, symptoms, investigations, treatment guidelines, complications and long-term effects of COVID-19. Myth busters and guidelines from WHO, IDSA and TUTH on testing, management and thromboprophylaxis are discussed.
1. The document discusses the etiological characteristics, clinical manifestations, and management of the novel coronavirus (COVID-19). It describes how the virus spreads through respiratory droplets and contact, and its symptoms which range from asymptomatic to severe.
2. Diagnosis involves PCR testing of respiratory samples, chest imaging showing pneumonia, and elevated inflammatory markers in severe cases. Treatment involves isolation, supportive care, and management of complications.
3. Prevention strategies include hand washing, physical distancing, and disinfecting surfaces. The document also proposes some Unani formulations that may provide adjuvant therapy for COVID-19.
This document provides information for nursing professionals on COVID-19 in post-acute care facilities. It discusses the origin and spread of the virus, symptoms, diagnosis and treatment. It emphasizes the importance of infection control through proper hand hygiene, use of personal protective equipment, monitoring residents, adjusting visitor policies, and encouraging employee responsibility. Key recommendations include limiting how many germs enter the facility, isolating symptomatic residents, and protecting healthcare workers through appropriate use of PPE.
This document summarizes information about COVID-19 for nursing professionals working in post-acute care facilities. It discusses the origin and spread of the virus, symptoms, diagnosis and treatment. It emphasizes the importance of strict infection control practices, including excellent hand hygiene, monitoring residents for symptoms, and providing appropriate personal protective equipment for healthcare workers. Healthcare workers are urged to take action to reduce transmission rates and prevent overwhelming local healthcare systems.
This document provides information for nursing professionals on COVID-19 in post-acute care facilities. It discusses the origin and spread of the virus, symptoms, diagnosis and treatment. It emphasizes the importance of infection control through hygiene, monitoring residents, appropriate use of PPE, encouraging employee responsibility and adjusting visitor policies. Key recommendations include limiting how germs enter the facility, isolating symptomatic residents, and protecting staff through proper PPE use.
The document discusses laboratory diagnostics for COVID-19. It describes how reverse transcriptase polymerase chain reaction (RT-PCR) tests performed on respiratory specimens like nasal or throat swabs are the current reference standard for diagnosis. Point-of-care tests and serological immunoassays that detect antibodies are also emerging. The document outlines considerations for different types of tests and discusses interpreting results, safety handling of specimens, and highlights the importance of diagnostic testing in controlling the pandemic.
Similar to Basic Contact tracing for Schools.pdf (20)
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Ear Solutions (ESPL)
Binaural hearing using two hearing aids instead of one offers numerous advantages, including improved sound localization, enhanced sound quality, better speech understanding in noise, reduced listening effort, and greater overall satisfaction. By leveraging the brain’s natural ability to process sound from both ears, binaural hearing aids provide a more balanced, clear, and comfortable hearing experience. If you or a loved one is considering hearing aids, consult with a hearing care professional at Ear Solutions hearing aid clinic in Mumbai to explore the benefits of binaural hearing and determine the best solution for your hearing needs. Embracing binaural hearing can lead to a richer, more engaging auditory experience and significantly improve your quality of life.
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)bkling
Your mindset is the way you make sense of the world around you. This lens influences the way you think, the way you feel, and how you might behave in certain situations. Let's talk about mindset myths that can get us into trouble and ways to cultivate a mindset to support your cancer survivorship in authentic ways. Let’s Talk About It!
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Joker Wigs has been a one-stop-shop for hair products for over 26 years. We provide high-quality hair wigs, hair extensions, hair toppers, hair patch, and more for both men and women.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...rightmanforbloodline
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
MYASTHENIA GRAVIS POWER POINT PRESENTATIONblessyjannu21
Myasthenia gravis is a neurological disease. It affects the grave muscles in our body. Myasthenia gravis affects how the nerves communicate with the muscles. Drooping eyelids and/or double vision are often the first noticeable sign. It is involving the muscles controlling the eyes movement, facial expression, chewing and swallowing. It also effects the muscles neck and lip movement and respiration.
It is a neuromuscular disease characterized by abnormal weakness of voluntary muscles that improved with rest and the administration of anti-cholinesterase drugs.
The person may find difficult to stand, lift objects and speak or swallow. Medications and surgery can help the patient to relieve the symptoms of this lifelong illness.
3. DATA SOURCE
▪ Hospital Reports
▪ Self-Reported
▪ Barangay Reported
▪ Health Center Reported
▪ DOH (CDRS)
▪ DOH (LINELIST)
**COVID Document
Repository System
4. DATA SOURCE
▪ Hospital Reports
▪ Self-Reported
▪ Barangay Reported
▪ Health Center Reported
▪ DOH (CDRS)
▪ DOH (LINELIST)
DATA MANAGEMENT
TEAM
PUBLIC HEALTH
SURVEILLANCE UNIT
**Data process
and endorsement
**COVID Document
Repository System
**Data encoding
5. Workplace Surveillance
• Monitoring and Contact
Tracing of QC
Workplaces/Companies
CONTACT TRACING
(Health Center)
Health Center
(Field/Phone Contact Tracing)
• Validation of Cases
• Contact Tracing
• Swabbing of Close Contact
• Analysis of situation on the area
• Monitoring of Cases
6. DATA ANALYSIS
- Daily COVID-19
Report
- Analysis of
COVID-19 Data
CONTACT TRACING
(Health Center)
Health Center
(Field/Phone Contact Tracing)
• Validation of Cases
• Contact Tracing
• Swabbing of Close Contact
• Analysis of situation on the area
• Monitoring of Cases
Workplace Surveillance
• Monitoring and Contact Tracing
of QC Workplaces/Companies
DATA
PROCESSING
7. SARS-CORONAVIRUS 2
• Coronaviruses (CoVs) are a large number
of viruses
✓ You need a powerful microscopes to see
them
✓ “Corona” means crown
SARS-CORONAVIRUS 2
8. SARS-CORONAVIRUS 2
• This is the third coronavirus to have done
so since 2002
✓ Severe Acute Respiratory Syndrome
(SARS) CoV emerged in Guangdong, China,
in 2002.
✓ Middle Eastern Respiratory Syndrome
(MERS) CoV emerged in the Middle east in
2012
✓ SARS Cov 2 emerged in Wuhan, China in
2019
SARS-CORONAVIRUS 2
9. SARS-CORONAVIRUS 2
• The virus primarily spreads between
people through close contact and via
aerosols and respiratory droplets that are
exhaled when talking, breathing, or
otherwise exhaling, as well as those
produced from coughs or sneezes.
• The World Health Organization (WHO)
on March 11, 2020, has declared the novel
coronavirus (COVID-19) outbreak a global
pandemic
SARS-CORONAVIRUS 2
10. SARS-CORONAVIRUS 2
• SARS-CoV-2 probably originated in bats.
• They Infect a side range of mammals and
birds
• Special coronaviruses have jumped species
and can be transmitted between people.
• Bats are considered the most likely natural
reservoir of SARS-CoV-2. Differences
between the bat coronavirus and
SARS-CoV-2 suggest that humans may have
been infected via an intermediate host.
11. • Transmission of SARS-CoV-1 and 2 from mammals as
biological carriers to human.
12. • Reorient the School clinic teachers
and safety officers about basics of
Covid-19 and basic contact tracing
• Shift to an electronic information
system for better information
sharing (TKC)
• To Utilize TKC as a self reporting
tool in monitoring health status of
school staff, teachers and
students
OBJECTIVES:
15. 1. SUSPECTED CASES
- A suspect case is a person who
meets the clinical and epidemiological
criteria.
TYPES OF PATIENTS
16. ✓ SUSPECTED CASES A suspect case
is a person who meets the clinical
and epidemiological criteria.
TYPES OF PATIENTS
CLINICAL CRITERIA
Acute onset of fever AND
cough OR acute onset of
ANY THREE or MORE of
the ff signs and symptoms
(fever, cough, weakness,
fatigue, headache, myalgia,
sore throat, coryza, dyspnea,
nausea/vomiting, diarrhea,
altered mental status)
EPIDEMILOGICAL CRITERIA
• Residing or working in an area with
high-risk of transmission (closed
settings) OR health settings anytime
within the 14 days prior to symptom
onset
• Travel to area with community
transmission anytime within the 14
days prior to symptom onset
• Patient with severe acute respiratory
illness
17. TYPES OF PATIENTS
2. PROBABLE CASES
A probable case meets the following
definitions:
✓ A patient who meets the clinical
criteria AND is a contact of a
probable or confirmed case, or
epidemiologically linked to a
cluster of cases with at least one
confirmed case within the cluster.
18. TYPES OF PATIENTS
PROBABLE CASES
✓ A person with recent onset of
anosmia (loss of smell) or ageusia
(loss of taste) in the absence of any
other identified cause
✓ A suspect case with chest imaging
showing findings suggestive of
COVID-19 disease.
19. TYPES OF PATIENTS
3. CONFIRMED CASES
✓ Patients with Positive Results from
a Recognized Laboratory.
RT-PCR (Real Time Polymerase Chain Reaction)
RNA DETECTED and Positive Antigen Test
20. TYPES OF CONFIRMED CASES:
ASYMPTOMATIC CASE
Patients with no sign or
symptoms
SYMPTOMATIC CASE
Patients with sign or
symptoms
✓ Cough
✓ Colds
✓ Fever
✓ Sore Throat
✓ Tiredness
✓ Loss of taste
✓ Loss of smell
✓ Diarrhea
COMMON SIGNS
& SYMPTOMS
21. Extreme Fever
Chest pain When
Breathing
Loss of speech or
mobility, or confusion
Shortness of Breath or
difficulty in breathing
SEVERE SYMPTOMS
Bluish lips or face (May
indicate lack of oxygen)
22. QUARANTINE VS ISOLATION
Quarantine – The restriction of movement, or
separation from the rest of the population, of
healthy persons who may have been exposed
to the virus, with the objective of monitoring
their symptoms and ensuring early detection
of cases (MC No. 2020-0020)
Isolation – the separation of ill or infected
persons from others to prevent the spread
of infection or contamination (MC No. 2020-
0020)
23. ✓ During sneezes, coughs,
talking. (Landing in the eyes,
nose or mouth of people.)
✓ Touching surfaces that may
have viruses from someone’s
respiratory droplets (Hands
infected with virus can travel
to eyes, nose or mouth by
touching it
INFECTIOUS RESPIRATORY
DROPLETS AND AEROSOLS
CAN TRAVEL:
24. • Time from when someone is
infected until symptoms
develop.
• The SARS-Cov-2 incubation
period ranges from 2-14
days.
• Average of people will
become ill by 5 days after they
get infected.
INCUBATION PERIOD
25. INFECTIOUS PERIOD OF COVID-19
SYMPTOMATIC
Two (2) days before the
onset of Symptoms until
its disappearance.
ONSET OF
SYMPTOMS
INFECTIOUS PERIOD
26. INFECTIOUS PERIOD OF COVID-19
ASYMPTOMATIC
Two (2) days before and
ten (10) days after the
swab test
SWAB
TEST
INFECTIOUS PERIOD
27. • Someone who was at least 2 meters
away from a Confirmed case from a
cumulative total of 15minutes or
more over a 24-hour period.
• Direct physical contact with a
probable or a confirmed case.
CLOSE CONTACTS
28. 1. MILD CASE - patients with mild
symptoms and stable vital signs.
Unless the patient belongs to high-
risk subgroups or has
comorbidities, they are often not
admitted to a treatment facility
2. MODERATE CASE - patients with
difficulty breathing, altered mental
status, considered high-risk or in
need of hospital care
CASE CLASSIFICATION
29. 3. SEVERE CASE - confirmed case
classified as either severe pneumonia
or suspect, probable or confirmed
case of COVID-19, exhibiting severe
(shortness of breath, confusion, or
50% lung involvement on imaging)
signs or symptoms.
CASE CLASSIFICATION
30. 4. CRITICAL CASE - or suspect, probable
or confirmed case of COVID-19 with
impending or ongoing respiratory
failure, in need of mechanical
ventilation, or with evidence of end-
organ damage
CASE CLASSIFICATION
31. COORDINATED OPERATIONS TO
DEFEAT EPIDEMIC (COVID-19 CODE
TEAM)
Contingency Plan:
1. Early Detection of Signs and Symptoms
2. Management and Identification of Signs and Symptoms in
the isolation room while waiting for the School Health
Officer
3. Notification of the QCESU/Health
Centers/parents/guardians.
4. Transport of the individual from school to health facility/
home.
5. Contact Tracing
32. COORDINATED OPERATIONS TO
DEFEAT EPIDEMIC (COVID-19 CODE
TEAM)
1. Early Detection of COVID-19
Self-Check
before
Leaving
Before leaving for household visits, each students, teacher
or personnel should self-assess using the following
questions:
If the answer is No to all
three symptom questions
(cough, fever, fast
breathing) after 14 days,
then it is cleared to go the
school
But if the
student/teacher/personnel
is experiencing symptoms
of COVID-19 they should
inform their teachers or
supervisors, self report and
undergo immediate
quarantine
Is any member of
my household
presenting any of
COVID-19
symptoms -
cough, fever and
fast breathing?
Have I come into
close contact (<2
meters) with
anyone displaying
any of the COVID-
19 symptoms in
the last 14 days?
Am I having any of
the following
COVID-19
symptoms -
cough, fever and
fast breathing?
33. COORDINATED OPERATIONS TO
DEFEAT EPIDEMIC (COVID-19 CODE
TEAM)
1. Early Detection of COVID-19
Upon
Arrival
in the
School
Upon arrival students/teachers/personnel are required for
temperature check.
Isolation in a safe place
(free from stigma) until a
School Clinic Teacher or
Safety Officer came
Assessment will be done by the
School Clinic Teacher/Safety
Officer if the individual needs to
be brought in the hospital or for
home observation
Student/Teacher/Personnel who is experiencing COVID-19
Symptoms
The School Clinic Teacher will then immediately notify the
CESU for immediate Contact tracing.
34. COORDINATED OPERATIONS TO
DEFEAT EPIDEMIC (COVID-19 CODE
TEAM)
2. Management of Signs and Symptoms
When to Get Emergency Care
Call for emergency care or if the individual of any age has any of the
warning or emergency signs below:
• Fast breathing or trouble breathing
• Bluish or gray skin color
• Not drinking enough fluids (not going to the bathroom or making as
much urine as they normally do)
• Severe or persistent vomiting
• Not waking up or not interacting
• Being so irritable that the child does not want to be held
• Flu-like symptoms improve but then return with fever and worse cough
• Has other conditions (like heart or lung disease, diabetes, or asthma)
and develops flu symptoms, including a fever and/or cough.
35. COORDINATED OPERATIONS TO
DEFEAT EPIDEMIC (COVID-19 CODE
TEAM)
3. Notification of the Authorities.
School- QCESU
reporting
system
School Clinic Teachers/Safety Officer will inform and
report the cases to QCESU through email
The Contact tracing team in
the health centers will
provide advise for
Isolation/Quarantine and
assist/guide the patient for
booking of the free swab
test in the Health Centers.
The Contact tracing team
will also be the one to
advise the individual
regarding the
quarantine/Isolation Period
depending on his/her case.
The QCESU now will notify and endorse the cases to the
Health Center Contact tracing team
36. Suspected
case/Close
Contacts
Endorse
ment of
Case
Reported
Advise for
quarantine/
Isolation
and testing
Identification
Reporting and Notifying
Suspected Patient with
symptoms and Close
Contacts will be
Identified by the school
Safety Officer through
initial contact tracing
SO/School Clinic
Teacher will initiate
initial Contact tracing
and report the cases
to QCESU
The Contact tracing team will
provide advise for
Quarantine/Isolation and will guide
the Individual for the Free swab test
in the nearest health center
Barangay Health Center
Case management
Quarantine/Isolation
The cases will be
endorsed to the
nearest Health Center
of the case for contact
tracing and
verification
Quaranti
ned
/Isolated
37. Pertinent case details:
• Full Name
• Birthday
• Age
• Address (Street, Barangay, City)
• Contact number
• Case status (Symptomatic or Asymptomatic)
• Symptoms and onset
• Possible exposure (Date, Place, Person,
Nature)
• Close Contacts (with timeline)
40. Local Government of Quezon City
QUEZON CITY EPIDEMIOLOGY AND SURVEILLANCE UNIT
QCXperience, QC Memorial Circle, Diliman, Quezon City
Email: qcsurveillance@quezoncity.gov.ph
Contact No: 8703-2759/8703-4398